Ophthalmic Adaptive Optics (AO) Retinal Imaging System

The contract involves the acquisition of one Ophthalmic Adaptive Optics (AO) Retinal Imaging System by the Food and Drug Administration (FDA), specifically through the Center for Devices and Radiological Health's Division of Biomedical Physics. This advanced imaging system will be utilized to support research related to retinal imaging, biomarker development, and regulatory science at the FDA’s White Oak Campus in Silver Spring, Maryland. The system must be delivered and installed at the designated location within Building WO62, Room G101. This procurement is issued under solicitation number RFQ-FDA-133666, with a response deadline set for mid-June 2026. It is a total small business set-aside opportunity, adhering to SBA guidelines, and categorized under the NAICS code 334516, which pertains to electromagnetic radiation research and measurement equipment manufacturing. The contract is managed by the FDA Office of Acquisition and Grant Services, part of the Department of Health and Human Services. Key contacts for this acquisition include Freshta Javid as the primary point of contact and Sarah Hussain as a secondary contact. The place of performance is Silver Spring, MD, while the contracting office is located in Rockville, MD.